FreeTheAI

MedWellAI Narrows Net Losses in Fiscal 2026 Amid Strategic Shift

MixedMedium impact
MWAI$0.3700 34.55%

MedWellAI, Inc. (OTC:MWAI) reported revenue of $527,857 for fiscal year 2026, an 11.2% decrease from $594,768 in the previous fiscal year. Despite the lower revenue, the company narrowed its net loss attributable to shareholders to $1,589,465, or $(0.24) per diluted share. That marks an improvement from a net loss of $3,607,145, or $(0.49) per share, recorded in fiscal 2025. Shares of the company gained 34.55% to trade at $0.37.

The improved net loss came as MedWellAI executed a major corporate pivot, moving away from digital asset mining to build a health and wellness e-commerce platform focused on GLP-1 treatments and in-office products. Regulatory obstacles created significant pressure on legacy channels, prompting the business to exit direct online sales entirely and causing commission revenues to fall from $576.9K to $437.9K. As part of its transition, the company recorded impairments and discontinued old operations while taking a 51% controlling stake in Healthy Lifestyle.

Looking ahead, investors will be monitoring the performance of MedWellAI's newly established healthcare ventures, including an automated 503B pharmacy platform. With legacy digital revenue streams effectively eliminated, the company's growth now depends on successfully scaling its health products and establishing sustainable revenue channels under its new strategy.

Key points

  • MedWellAI generated fiscal 2026 revenue of $527,857, down 11.2% year over year from $594,768.
  • Net losses attributable to the company narrowed to $1.59 million, or $(0.24) per share, compared to $3.61 million, or $(0.49) per share, in fiscal 2025.
  • The company pivoted from cryptocurrency mining to a health and wellness e-commerce platform centered on GLP-1 products.
  • Regulatory obstacles forced MedWellAI to exit direct online sales, bringing online revenue down to zero.
  • Shares of MedWellAI rose 34.55% to $0.37 following the report.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

What were MedWellAI's fiscal 2026 financial results?

MedWellAI reported fiscal 2026 revenue of $527,857, down 11.2% from fiscal 2025. Net loss attributable to the company narrowed to $1,589,465, or $(0.24) per diluted share, compared to a loss of $3,607,145, or $(0.49) per share, in the prior year.

Why did MedWellAI exit direct online sales?

MedWellAI exited its online direct sales business due to regulatory hurdles, which reduced its online revenue to zero and contributed to lower overall commission revenues for the fiscal year.

What is MedWellAI's new business focus?

MedWellAI pivoted away from digital asset mining to focus on a health and wellness e-commerce platform centered on GLP-1 and in-office products, including an automated 503B pharmacy platform.